查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球動物授精市場-2022-2029
市場調查報告書
商品編碼
1129269

全球動物授精市場-2022-2029

Global Veterinary Artificial Insemination Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

預計動物人工授精應用的技術進步將推動市場增長。

佛羅裡達大學創建了面向市場的乳製品 (MOD) 飼料配方工具 (RAFT) 移動應用程序。該軟件有 iOS 和 Android 版本，將根據該國的需求量身定制，然後供盧旺達農民使用，為他們的奶牛創造均衡的飲食。第 2 章提出了農民在人工授精或自然交配後確定奶牛妊娠狀態的解決方案。未懷孕的奶牛可以通過早期診斷技術盡快重新開始配種或人工授精。有了這項技術，奶農可以確保每頭奶牛每年生一頭小牛，提高繁殖效率。這種效果還可以確保奶牛在其一生中生產更多的牛奶，這有利於奶農。由於這些原因，預計市場在預測期內將擴大。

約束

與動物育種相關的風險，例如疾病和傳染病的流行、合格獸醫短缺、高成本以及限制原材料進口的嚴格政府法規，將在預測期內阻礙市場。因素

行業分析

動物人工授精市場根據供應鏈分析、價格分析等各種行業因素對市場進行深入分析。

COVID-19 影響分析

COVID-19 大流行對醫療保健系統和市場產生了適度影響。大流行擾亂了畜禽供應鏈，減少了對動物食品銷售的需求。動物因飲食和獸醫護理不足而遭受痛苦，包括需要及時進行人工授精、妊娠試驗和驅蟲。例如，2020 年 6 月，畜牧業部啟動了一項計劃，為家禽養殖戶和業主提供電話援助，以保護農民和工人免受 COVID-19 的侵害。此外，在 COVID-19 大流行期間，人工授精被送到農民家門口。因此，這些活動導致市場擴張。

另一方面，由於對牛奶和乳製品 (MMP) 的需求顯著下降，COVID-19 停工對牛奶生產商和加工商產生了負面影響。結果，MMP 的價格下跌，大大增加了其利益相關者的損失。牛奶生產商每天的經濟損失估計為 112.3 億日元，其中超過四分之一發生在北方邦和拉賈斯坦邦這兩個州。這些損失主要集中在九個州。降低價格帶來的消費者福利改善不足以完全補償生產者，造成每天 66.7 億日元的經濟損失無法挽回。因此，預計封鎖將產生長期陰影，並取決於隨後的寬鬆措施，影響牛奶生產和乳製品行業的盈利能力。如上所述，市場受到影響，但隨著經濟活動的恢復，預計將迅速恢復。

全球動物授精市場報告將提供對大約 45 多個市場數據表、40 多個數字和 180 頁的訪問。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因子
    • 驅動程序
      • 預計動物人工授精應用的技術進步將推動市場增長。
    • 限制因素
      • 動物人工授精的高成本預計將阻礙市場增長。
    • 機會
    • 影響分析

第五章行業分析

  • 供應鏈分析
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按動物類型

  • 牛
  • 豬
  • 綿羊/山羊
  • 馬
  • 其他

第 8 章按產品類型

  • 正常精液
  • 性交精液

第九章技術

  • 宮腔管腹膜人工授精
  • 宮頸人工授精
  • 宮腔內人工授精
  • 輸卵管內人工授精

第 10 章，最終用戶

  • 獸醫醫院
  • 獸醫診所
  • 動物育種
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 13 章公司簡介

  • IMV Technologies
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Neogen Corporation
  • Bovine ELite LLC
  • Agtech Inc.
  • Zoetis Inc.
  • Jorgensen Labs
  • Revival Animal Health
  • Merck Animal Health
  • Swine Genetics International
  • Santa Cruz Biotechnology

第 14 章全球動物授精市場-DataM

簡介目錄
Product Code: DMVH5841

Market Overview

Veterinary Artificial Insemination Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Artificial insemination involves creating a pregnancy without engaging in sexual activity by injecting sperm or semen into the female uterus or cervix. By using fresh, uncooked, or frozen semen straw, it is possible to breed cattle. In vivo fertilization uses artificial insemination to make an animal pregnant. Because it works better during the animal's heat cycle, this technique is also employed in sperm donation and reproductive technology, allowing animals to reproduce on schedule. Enhancing the genetics and reproduction of animals using veterinary artificial insemination is a unique biotechnology approach.

Market Dynamics

Technological advancement in veterinary artificial insemination applications is expected to drive market growth.

The University of Florida created the Market Oriented Dairy (MOD) Ration Formulation Tool (RAFT) mobile application. Before being used by farmers in Rwanda to build a balanced ration for their dairy cattle, the software, which is available in iOS and Android versions, will be tailored for the country's needs. After artificial insemination or natural mating, a solution to help farmers determine the pregnant state of cattle is proposed in the second section. A non-pregnant cow can resume mating or artificial insemination as soon as feasible with the early diagnostic technique. With this technique, farmers can ensure that each of their cows produces a calf yearly, achieving breeding efficiency. Moreover, this effectiveness will guarantee that cows produce more milk throughout their lives and benefit farmers. Thus, from the above statements, the market is expected to boost in the forecast period.

Restraint

Risks related to animal breeding, including the spread of disease and infection, a lack of qualified veterinarians, the high cost of this procedure, and stringent government regulations restricting the import of raw materials are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The veterinary artificial insemination market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The pandemic has disrupted the supply chains for livestock and poultry, reducing the demand for the sale of animal food. Due to inadequate diet and veterinary treatment, including the requirement for timely artificial insemination, pregnancy checks, and deworming, animals suffered. For instance, the Animal Husbandry Department of India started a program in June 2020 that provided telephonic help to poultry farmers and owners to protect farmers and workers against COVID-19. Moreover, during the COVID-19 pandemic, artificial insemination was supplied to farmers' doorsteps. As a result, these activities have helped the market expand.

In contrast, the COVID-19 lockout has had a negative effect on milk producers and processors since there has been a considerable decrease in demand for milk and milk products (MMP). The resulting drop in MMP's pricing has greatly contributed to their stakeholders' losses. Preliminary estimates of economic losses to milk producers stand at 112.3 crores per day, with more than one-fourth of these losses coming from only two states, Uttar Pradesh and Rajasthan. These losses are heavily concentrated in nine states. The increase in consumer welfare brought on by price decreases is insufficient to fully compensate the producers, leaving 66.7 crores in daily economic losses unrecovered. Therefore, lockdown is predicted to cast a lengthy shadow, affecting milk output and the dairy industry's profitability depending on the subsequent mitigating measures taken. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Sexed Semen segment is expected to hold the largest market share in veterinary artificial insemination market

The sexed semen segment is expected to dominate in 2021. The segment benefits from the yields of various breeds, taking into account genetic modification, crossbreeding, and research on the development of certain breeds from sexed semen. According to the evidence, using both normal bovine semen for terminal crosses and sexed semen for purebreds increases meat production in dairy herds. Pregnancy rates in cattle receiving 2 million sexed sperm per insemination dose are almost 80% of those in cattle receiving conventional semen at standard sperm doses.

Nevertheless, since the growth of dairy heifers is essential for the dairy industry and advancements in sexing processes have boosted fertility, approximately 2 million bovine semen applied annually in the United States are sexed. Overall, the data show that, compared to artificial insemination with conventional semen, artificial insemination with sexed semen tends to improve the financial gain of dairy farmers. Additionally, according to the cost-benefit analysis, sexed semen can help the dairy herd expand more quickly and profitably by boosting the number of heifer deliveries. For instance, Sexcel was created using a cutting-edge, patented method for sexing bovine semen, utilizing ABS's best genetics. With this cutting-edge technology, the cells are not subjected to the tremendous pressures, electric currents, and shear forces required to make the sexed semen that farmers can access. Sexcel Sexed Genetics is available for Holstein, Jersey, and Norwegian Red. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global veterinary artificial insemination market

In 2021, North America accounted for the highest revenue share. The increased adoption of artificial insemination procedures in cattle, rising milk consumption and production of beef, growing awareness regarding artificial insemination, expansion and acquisitions by the key market players in the region are some factors the market is expected to boost in the forecast period. For instance, in the U.S., artificial insemination was used in breeding 80% of dairy animals. With over 90% of the market share in North America, the U.S. will be one of the major markets for artificial animal insemination (A.I.) procedures due to their greater adoption rate. Moreover, Semex and Nedap announced the growth of their productive relationship in January 2022. More nations now offer the Semex ai24 program with Nedap technology, allowing dairy farmers to enhance their herds' productivity and performance greatly. Additionally, In April 2021, Elanco Animal Health cooperated with Ducks Unlimited to support agriculture and environmental sustainability, particularly for beef cattle production across North America. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the veterinary artificial insemination market are IMV Technologies, Neogen Corporation, Bovine ELite LLC, Agtech Inc., Zoetis Inc., Jorgensen Labs, Revival Animal Health, Merck Animal Health, Swine Genetics International, Santa Cruz Biotechnology.

Zoetis Inc.:

Overview:

Zoetis is a global animal health company focusing on livestock and companion animals. It is involved in discovering, developing, producing, and marketing animal health drugs, vaccines, and diagnostic tools. Biodevices, genetic diagnostics, and precision livestock farming supplement its goods. The business, among other things, sells vaccines, parasiticides, anti-infective treatments, and medicated feed additives. Its client supply services (CSS) organization also provides contract manufacturing services to other parties. The company has manufacturing sites worldwide. It sells goods through direct marketing channels and distributors in the Americas, Europe, Africa, Asia, and Australia to veterinarians, livestock producers, and people who raise and care for farm and companion animals.

Product Portfolio:

LUTALYSE: The most widely used and approved prostaglandin on the market is LUTALYSE Injection (dinoprost tromethamine injection), which veterinarians recommend. Program for synchronizing artificial insemination with LUTALYSE can increase breeding success. Today, producers and veterinarians have more alternatives than ever for employing LUTALYSE in reproduction programs. Now that FACTREL Injection (gonadorelin injection) has received approval, it can also be used in conjunction with LUTALYSE to synchronize estrous cycles and enable fixed-time artificial insemination (FTAI) in dairy cows that are nursing.

The global veterinary artificial insemination market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancement in veterinary artificial insemination applications is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of veterinary artificial insemination is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Animal Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 7.1.2. Market Attractiveness Index, By Animal Type Segment
  • 7.2. Cattle*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Swine
  • 7.4. Ovine & Caprine
  • 7.5. Equine
  • 7.6. Others

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type Segment
  • 8.2. Normal Semen*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Sexed Semen

9. By Technique

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 9.1.2. Market Attractiveness Index, By Technique Segment
  • 9.2. Intrauterine Tub peritoneal Insemination*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Intracervical Insemination
  • 9.4. Intrauterine Insemination
  • 9.5. Intratubal Insemination

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Veterinary Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Veterinary Clinics
  • 10.4. Animal Husbandry
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. IMV Technologies*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Neogen Corporation
  • 13.3. Bovine ELite LLC
  • 13.4. Agtech Inc.
  • 13.5. Zoetis Inc.
  • 13.6. Jorgensen Labs
  • 13.7. Revival Animal Health
  • 13.8. Merck Animal Health
  • 13.9. Swine Genetics International
  • 13.10. Santa Cruz Biotechnology

LIST NOT EXHAUSTIVE

14. Global Veterinary Artificial Insemination Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us